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Summary 
Dendritic cells (DC), the most efficient antigen-presenting cells, are well equipped for activa- 
tion of naive CD4 + T  cells by their expression of high levels of major histocompatibility com- 
plex  and  costimulator  molecules.  We  now  demonstrate  that  some  DC  are  equally  well 
equipped  for  killing  these  same  T  cells.  Murine  splenic  DC  consist  of both  conventional 
CDSot-  DC and a major population of CD8cx  + DC. Whereas CDS-  DC induce a vigorous 
proliferative response in CD4 T  cells,  CD8 + DC induce a lesser response that is associated with 
marked T  cell apoptosis. By using various mixtures of T  cells and DC from Fas-mutant Ipr/Ipr 
mice and Fas-ligand (FasL)  mutant gld/gld mice, we show this death is due to interaction of Fas 
on activated T  cells with FasL on CD8 + DC. Furthermore, we show by direct surface staining 
that CD8 + DC, but not CD8-  DC, express  FasL at high levels.  These findings indicate  that 
FasL  + CD8 + DC are a specialized subgroup of DC with a role in the regulation of the response 
of primary peripheral T  cells. 
D 
endritic  cells  (DC) ~ are APCs of hemopoietic origin, 
found  in  many  tissues  but  most  abundant  in  the 
T-dependent areas of lymphoid organs. Only DC have the 
capacity to activate naive T  cells (1). DC from murine lym- 
phoid organs can be identified by their expression  of high 
levels  of class  II MHC  proteins  or of the  integrin  CD11c 
(2-4).  A  substantial  proportion  of  murine  DC  express 
CD8ot,  although  this  is  only  evident  if the  DC  are  effi- 
ciently released  from the  tissue,  as  in  our recent  isolation 
procedure  (5,  6).  This direct procedure avoids cukure and 
adhesion  steps,  thus  maintaining  DC  in  a  physiologically 
native  state.  In  the  present  study  we  have  used  mAbs 
against CD11c and CDSct to sort pure splenic  CD8 +  and 
CD8-  DC  from such DC  preparations.  To  elucidate  the 
functional  differences  between  CD8 +  and  CD8-  splenic 
DC, we first tested their capacity to stimulate purified allo- 
geneic  CD4 T  cells in a primary MLR. The general rele- 
vance of the findings from the MLtL system was then tested 
in a specific response to a defined peptide antigen. 
Our initial  resuks  indicated  that  CD8 +  DC  caused the 
apoptotic death  of activated  CD4  T  cells.  Recent reports 
(7,  8)  indicate  that  a  signal for the  apoptosis of mature  T 
cells is delivered through the Fas molecule (CD95/APO-1) 
expressed on the surface of activated T  cells.  The hgand for 
Fas (FasL/CD95L) has been demonstrated on the surface of 
T  cells after activation (9,  10),  and it has been shown that 
1Abbreviations used in this paper: DC, dendritic cell(s); FasL, Fas-ligand; mu, 
murine; PI, propidium iodide; TdT,  terminal deoxynucleotidyl trans- 
ferase; TUNEL, TdT-mediated dUTP nick end labeling. 
even a single  T  cell can kill itself by Fas-FasL interaction 
(11-13).  This  is  considered  to  be  a  physiological control 
system preventing excess T  cell proliferation.  This control 
system is disregulated in mouse strains with functional mu- 
tations for Fas (lpr/lpr [14]) or FasL @a/eta [10, 15]) (9, 16, 
17). We therefore used these mutant mouse strains to ana- 
lyze Fas/FasL involvement in DC-T  cell interactions.  The 
system we now describe involves FasL expression by a ma- 
jor population of DC, potentially regulating or eliminating 
CD4 T  cell responses at the initial step of T  cell activation 
by an APC. 
Materials and Methods 
Animals.  The  normal  mouse  strains  used  were  C57BL/6J 
Wehi (]36) (H-2b), CBA/J (H-2k), BALB/c (H-2O), and C3H/HeJ 
(H-2k). The mutant mouse strains used were C3H/HeJlpr (C3H.lpr) 
(H-2k), C3H/HeJgld (C3H.gld) (H-2k), and B6Srrm.C3H-Fasl(gld) 
(B6.gld)  (H-2b).  The hemagglutinin-specific class II MHC [-E  d- 
restricted  TCP,.-transgenic  mice,  on  a  BALB/c  (H-2  d)  back- 
ground and heterozygous for the transgene,  were originally  ob- 
tained from H. yon Boehmer (Basel Institute for Immunology, 
Basel,  Switzerland)  and  are  described  elsewhere  (18).  All  mice 
were bred under specific pathogen-free conditions at The Walter 
and Eliza Hall Institute,  except the B6.gld mice, which were pur- 
chased  from The Jackson Laboratory (Bar Harbor, ME).  For all 
experiments,  5-6 wk-old female mice were used. 
Isolation of DC.  The procedure has been described previously 
(5). Briefly,  mild collagenase  digestion  for 25 rain at room tem- 
perature and EDTA treatment were applied  to release DC from 
murine spleen fragments, after which all procedures were at 0-4~ 
Light density cells were selected  by centrifugation in Nycodenz 
1789  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/04/1789/08 $2.00 
Volume 183  April 1996  1789-1796 medium (Nycomed Pharma, Oslo, Norway; 1.078 g/cm  3, pH 7.2, 
0.308 osmolar). These cells were coated with mAb against CD3, 
CD4, Thy 1, IL-2R.ot, Gr-1, Mac-l, F4/80 antigen, FcP,,II, B220, 
and erythrocyte antigen TER119; non-DC were then removed 
using anti-Ig-coated magnetic beads  (Dynabeads,  Dynal, Oslo). 
The enriched cells ("~70% DC)  were stained  with anti-CDllc 
(N418  [4]) and with anti-CD8 (PharMingen, San Diego, CA), 
together with propidium iodide (PI) to allow rejection of dead 
cells. CD11c  + DC, either the total population or separated into 
CD8 + and CD8- fractions,  were then obtained by sorting on a 
FACStar Plus  |  instrument (Becton Dickinson & Co., San Jose, CA). 
Reanalysis of the sorted cell populations confirmed purity 998%. 
Purification ofCD4 T Cells.  CD4 T cells were isolated from the 
lymph nodes of the appropriate  mice by coating lymphocyte sus- 
pensions with  saturating levels  of mAb recognizing CD8  (53- 
6.7), MHC class II (M5/114), and red blood cells (TER 119). In 
some experiments, mAb recognizing CD44 (IM7.81)  was added 
to deplete any preactivated  T cells and so select for naive CD4 T 
cells. The cells were washed  and coated cells as well as B  cells 
were  then removed using a  1:1  mixture of anti-rat and anti- 
mouse IgG-coupled magnetic beads (Dynabeads,  Dynal) at a 8:1 
bead-to-cell ratio.  The recovered cells were 98% pure, as deter- 
mined by FACS  |  analysis. For the isolation of CD4 T  cells from 
C3H,  C3H.Ipr  and B6.gld mice,  anti-B220 (RA3-6B2) was in- 
cluded in the depletion to exclude any B220 + T cells (19). 
Mixed Leukocyte and Antigen-specific Cultures.  The MLR assays 
were carried out in V-bottomed 96-well cukure plates to ensure 
efficient DC-T cell contact. CD4 T cells (20,000) were mixed with 
various numbers (500-4,000) of DC in 0.2 ml modified, RPMI- 
1640  medium  (GIBCO  BRL,  Gaithersburg,  MD)  containing 
10%  FCS  (Commonwealth  Serum  Laboratories,  Melbourne, 
Australia) and 10 -4 M  2-mercaptoethanol; they were then incu- 
bated at 37~  in humidified 10% CO2-in-air for 1-6 d. In some 
experiments, exogenous routine (mu)  rlL-2 (Immunex, Seattle, 
WA)  at  100  U/ml was  added.  For the  antigen-specific assays, 
CD4  T  cells from heterozygous hemagglutinin-specific, TCR- 
transgenic  mice (18) were prepared as described  above;  85% ex- 
pressed the transgenic  TCR. These CD4 T  cells (20,000)  were 
cultured with  titrating numbers of splenic  DC  from  BALB/c 
mice, together with the specific peptide (FEtkFEIFPK)  at 1 ~g/ 
ml. For thymidine incorporation, proliferation assay cultures were 
pulsed at the end of the incubation period with 0.5 I*Ci [3H]thy- 
midine (ICN, Irvine, CA) for 12 h; the cells were then harvested 
on glass fiber sheets for counting. A gas-phase [3 counter was used 
that  had  an ~20-fold lower sensitivity  than liquid scintillation 
counting. Thymidine pulses of 6--16 h  gave similar results.  For 
cell-counting  experiments, 10 replicate cultures were pooled after 
1-6 d of incubation and centrifuged at 500 g for 7 rain. The cells 
were resuspended  in 200  I.tl EDTA-containing medium to dis- 
rupt clumps,  then diluted in eosin-containing medium; viable/ 
eosin-excluding  cells were counted in duplicate under phase con- 
trast microscopy. 
Assays  for Apoptosis.  DC  (2,000)  were cultured with 20,000 
CD4 T cells for 3 d as described above; pools of 12 cultures were 
then harvested.  For analysis of DNA content, the cells were re- 
suspended in 200 Ixl saline, containing  0.1% sodium acetate, 0.2% 
Triton X-100, and 0.005% PI, then analyzed on the FACS  |  For 
the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP 
nick end labeling (TUNEL) assay, the procedure was similar to 
that ofSgonc et al. (20), involving  incubation of fixed, permeabi- 
lized cells with FITC-12-dUTP (Boehringer Mannheim, Mann- 
heim, Germany), dATP, and TdT (Promega,  Madison, WI) to 
label  apoptotic  cells. Cells  were  then  analyzed  by  FACS  |  for 
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Figure  1.  The  distribution of CD11c and CD8~x on DC-enriched 
spleen preparations from B6 and BALB/c mice, showing the gates used 
for  sorting. Enriched DC  were prepared and stained with  mAb for 
FACS  |  analysis  as described in Materials and Methods. Results are typical 
of over 30 experiments. 
FITC-fluorescence and forward  light scatter.  Negative controls 
omitting TdT gave no FITC labeling. 
Staining  for FasL Expression.  Purified but not FACS| 
DC (as described  above) were first incubated at 106 cells/sample 
with 0.1 mg/ml mouse Ig, 10% goat serum, and saturating levels of 
anti-FcR mAb 2.4G2 for  10 rain at 0-4  ~ to block Fc receptor 
binding  and minimize unspecific binding. The muFas-Fc fusion pro- 
tein (provided by D. Lynch, Immunex) was added at 50 ~g/ml 
and incubated 30 rain. Cells were washed and stained with anti- 
human  IgG-FITC  (Caltag  Laboratories,  South  San  Francisco, 
CA), and blocked again with 0.3  mg/ml rat  Ig. The cells were 
then stained with CD8-PE and N418-biotin followed by Texas 
red-avidin (Caltag) and PI to allow identification of the DC sub- 
populations. The  background controls were  samples incubated 
with 50  I~g/ml purified human IgG instead of fusion protein. 
The cells were analyzed  for FasL FITC-fluorescence, gating on 
viable CD8  + or CD8- DC as in Fig. 1. 
Results 
Isolation ofDC Subpopulations.  The FACS  |  separation of 
B6 and BALB/c mouse splenic DC using mAb against CD11c 
(N418 [4]) and CD8oe (53-6.7) is illustrated in Fig. 1. Since 
we  found neither mAb caused inhibition nor stimulation 
when added to MLR cultures of unseparated DC and CD4 
T  cells, sorting on the basis of these two markers was un- 
likely to affect DC or T  cell function. Distinct CD8 + and 
CD8- populations of the CD11chig  h DC were seen in the 
spleen of all mouse strains studied.  Although the  relative 
proportions varied in a  mouse  strain-dependent manner, 
CD8 + DC were always more frequent in the spleen. The 
CD8  molecule  has  been  shown  to  be  in  the  form  of a 
CD8oeci  homodimer  and  to  be  synthesized  by  the  DC 
themselves  (5).  Both  DC  populations were  found to  ex- 
press high levels of class II MHC, as well as B7-1 and B7-2 
(data not shown). 
T  Cell-proliferative  Responses  to  CD8 +  and  CD8-  DC. 
CD4 T  cells from CBA mice proliferated in a dose-depen- 
dent manner in response to CD1 lc  high DC from B6 mouse 
spleen (Fig. 2 A). However, there was a marked difference 
in the extent ofT cell proliferation when CD8- and CD8 § 
DC were compared, with the CD8- DC consistently pro- 
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Figure  2.  The interaction  of sorted  DC populations  with allogeneic,  syngeneic,  or antigen-specific  CD4 T  cells, l~epresentative  experiments  are 
shown, with the values representing the mean +- SD of triplicate cultures. Combined data from 17 MLR experiments show that the difference between 
CD8 § and CD8- DC-stimulated MLk cultures is consistent and statistically significant (P <0.0001).  No exogenous  cytokines were added to the cul- 
tures. Proliferation  of CD4 T cells was assessed by [3H]thymidine incorporation  after a 12-h pulse. The background  with either CD4 T cells or DC cul- 
tured alone was <50 cpm.  (A) DC dose-response  of an allogeneic MLK proliferation  assay. CD4 T cells from CBA mice were stimulated with CD8- 
DC (O), CD8 + DC (O) and unseparated  splenic DC (') from B6 mice. Culture time was 3 d. (/3) Kinetics of an allogeneic MLR proliferation  assay. 
2,000 B6 CD8- DC (O) or CD8 + DC (C)) were combined with 20,000 CD4 T cells from CBA mice. CD4 T cells were also cultured alone (A). Cul- 
tures were pulsed with [3H]thymidine after 1-5 d. (C) A comparison of the DC dose-response  of an allogeneic and a syngeneic MLR proliferation assay. 
CD4 T cells from CBA mice were stimulated with CD8- or CD8 + DC from B6 mice (allogeneic response, shown ~,  -G-, respectively) or CBA 
mice (syngeneic response,  -~,  -~-, respectively) and cultured for 3 d. (D) DC dose-response  of a proliferation  assay, stimulating hemagglutinin-spe- 
cific TCl~-transgenic CD4 T cells with BALB/c splenic CD8  DC (0) and CD8  + DC (￿9  presenting the specific peptide. Culture time was 3 d. 
ducing a 2-10-fold greater CD4  T  cell response.  The CD4 
T  cell response to the unseparated  CDllc  high DC  (contain- 
ing CD8-  and CD8 +  DC  at a  ratio  of 1:3,  as found in the 
B6 spleen; Fig.  1) was intermediate and in accordance with 
the  proportions  of its  CD8-  and  CD8 +  DC  components. 
This  suggested  that  by  stimulation  with  unseparated  DC, 
both types of responses  occur side by side without influenc- 
ing each other.  The kinetics of the MLP,~  (Fig.  2/3)  showed 
that  the  difference  in  the  CD4  T  cell response  to  CD8- 
and  CD8 +  DC  persisted  over  the  entire  duration  of the 
MLP,.  rersponse  and  was  not  due  to  a  shift in  the peak  of 
proliferation.  The  CD8-  DC  gave T  cell stimulation  indi- 
ces 200-250-fold  above  the  T  cell background,  indicating 
they were potent stimualtors  of CD4  T  cells. Other alloge- 
neic  combinations  showed  the  same  difference  between 
CD8-  and CD8 + DC  (data not shown). 
When  DC  are  used  as  stimulators,  it  is  known  that  a 
small but definite syngeneic MLR. can be observed (21). This 
phenomenon  is believed to  mimic a  response  to  self-anti- 
gens.  As demonstrated  in Fig.  2  C, this syngeneic response 
was also greater with CD8-  than with CD8 + DC. 
To  determine  if the  allogeneic MLR  was  a  valid model 
of responses  to a specific antigen,  a defined peptide antigen 
from influenza hemagglutinin was added to cultures of CD4 
T  cells from hemagglutinin-specific, class II MHC-restricted 
TCR  transgenic  mice  together  with  syngeneic  CD8 +  or 
CD8-DC.  Results  equivalent  to  those  from  the  MLR 
were  obtained  (Fig.  2  D),  CD8-  DC  producing  much 
greater specific T  cell proliferation than CD8 + DC. 
Direct  Cell  Counts  on  Cultures  Stimulated  with  CD8  +  or 
CD8- DC.  To  obtain  a  more  direct measure  of cell ex- 
pansion than that obtained by [3H]thymidine uptake  assays, 
direct  cell counts  were  performed  on  the  MLR  cultures. 
This approach allowed blast cell formation as well as occur- 
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Figure 3.  Direct cell counts on cultures of CD4 T cells stimulated with 
allogeneic CD8- DC (0) and CD8 + DC (O), MLR cultures were set up 
as in Fig, 1 B. After 1--6 d, pools of  replicate cultures were counted under 
the microscope. The numbers of  viable cells per culture are shown. Exog- 
enous IL-2 at 100 U/ml was added to the cultures (bottom), 
rence of dead cells in the cultures to be monitored. CD8- 
DC  gave a greater accumulation of viable cells in the cul- 
tures than did CD8 + DC, resulting in a twofold increase of 
viable cells at the peak of response (Fig. 3). Associated with 
the reduced response, the CD8 + DC-sfimulated cultures con- 
tained about half the level of T  cell blasts, but more dead 
cells. This reduced T  cell response was not due to insuffi- 
cient production of IL-2 in the CD8 ~ DC-stimutated cul- 
tures. Although addition of exogenous  100 U/ml murlL-2 
enhanced  the  proliferative responses  to  both  CD8 +  and 
CD8-  DC,  it maintained the  marked difference between 
them  (Fig. 3).  These  results confirmed the differences be- 
Table 1.  Apoptosis  Analysis by Pl labeling 
tween  CD8 + or CD8-  DC  stimulation obtained with the 
[3HJthymidine uptake assays. 
Cellular DNA Analysis on Cultures Stimulated with CD8* 
or CD8- DC.  In view of the fact that in relative numbers 
more dead cells could be detected by microscope counting 
in cultures stimulated by splenic CD8 + DC, we performed 
PI staining of cells from day 3 MLR cultures of DC-stimu- 
lated CD4  T  cells to monitor their nuclear DNA  content. 
This allowed us to identify apoptotic cells as having hypo- 
diploid DNA  as well as to distinguish them from dividing 
cells with ongoing DNA  synthesis. Results, summarized in 
Table  1,  demonstrate  a  significantly larger  population  of 
apoptotic cells in CD4 T  cell cultures stimulated by CD8 + 
DC  (29%)  compared with those stimulated by CDS-  DC 
(14%).  In  addition,  more  dividing  cells  were  present  in 
CD8-  DC-stimulated cultures, supporting our earlier find- 
ings obtained with [3H]thymidine incorporation and direct 
cell counting. 
Evidence  for Fas-mediated Apoptosis of CD4 T Cells.  To as- 
sess the role of Fas in the observed apoptotic T  cell death, 
we  used  Fas-deficient  C3H/HeJlpr  CD4  T  cells  in  our 
MLR cultures (14, 19), stimulating them with B6 CD8 + or 
CD8-  DC  in  the  presence  of exogenous  IL-2  to  ensure 
this was  not a  limiting factor.  Whereas  control C3H/HeJ 
CD4  T  cells  gave  the  same  result  as  that  obtained  with 
CBA T  cells, namely a  greater response to CD8-  than  to 
CD8 +  DC  (Fig. 4  A),  Fas-deficient lpr CD4 +  T  cells re- 
sponded at least as well to  CD8 + as to  CD8-  DC  (Fig. 4 
/3).  Similar results were obtained in the absence of exoge- 
nous IL-2 (data not shown).  This demonstrates that lack of 
inherent stimulatory ability by CD8 + DC was not the rea- 
son  for the  reduced  response  of normal  T  cells.  The  de- 
creased  proliferation  appeared  rather  to  be  due  to  Fas- 
mediated killing of the CD4 T  cells after their activation by 
CD8 + DC. 
This  T  cell death was  further  analyzed by the  TUNEL 
technique  (20)  which  detects DNA  strand breaks  in  cells 
undergoing apoptosis (Fig. 4  C). Normal CD4 T  cells stim- 
ulated for 3 d by CD8 + DC showed ~20% apoptotic cells, 
a sixfotd increase compared with stimulation by CD8- DC; 
associated with this, the CD8 + DC again gave only half the 
number of blast cells compared with stimulation by CDS- 
DC. However, when lpr CD4 T  cells were used there were 
few  apoptotic  cells  and  an  equivalent  number  of blasts, 
Stimulating DC population 
DNA content of cultured CD4 T  cells 
<2n  2n  >2n 
(apoptotic cells)  (Go or G 1 cells)  (dividing cells) 
CD8+  29 +-. 1  61  +  1  10 +  1 
CD8-  14+  1  63-+  1  23 +  1 
2,000 DC isolated from B6 spleens were cultured with 20,000 CD4 T cells from CBA mice. After 3 d, cells  of pooled cultures were permeabilized, 
stained with PI, and analyzed for DNA content by flow cytometry. 2n designates the DNA content of a normal diploid cell. 
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Figure 4.  The response of normal and Fas-deficient  mice to allogeneic 
CD8- and CD8 § DC. All experiments have been repeated twice with 
similar results. Recombinant mouse 1L-2 at 100 U/ml was added to the 
cultures; these results obtained in the presence of exogenous IL-2 were 
confirmed in three experiments where IL-2 was not added to the cul- 
tures. Proliferation  was assessed as described in Fig. 2. The background 
with either CD4 T cells or DC cultured alone was <100 cpm. (A) Prolif- 
erative response of control C3H CD4 T cells to B6 CD8- DC (0) or 
CD8  § DC (O) after 3 d of culture. (B) Proliferative  response of mutant 
C3H.tpr CD4 T cells to B6 CDS- DC (0) or CD8 + DC (￿9  after 3 d of 
culture. (C) FACS  |  profiles of a combined TUNEL assay for apoptosis 
and forward light scatter analysis  for cell size. Samples consisted  of C3H 
and C3H.lpr  CD4 T cells stimulated  by B6 CD8- or CD8  + DC for 3 d. 
Cells that incorporated FITC-dUTP were classified  as apoptotic. 
whether stimulated by CD8- or CD8 + DC. The apoptotic 
cells detected were T  cells rather than DC, because at this 
time point T  cells were in vast excess in the cultures; the 
reduction of apoptotic  cells  in Ipr T  cell  cultures further 
validates this conclusion. These results demonstrate that Fas 
is involved in an early, postactivation T  cell death that lim- 
its the proliferative expansion of normal CD4 T  cells stim- 
ulated by CD8 + DC. 
Evidence  for FasL on CD8 + DC.  The possibility that APC 
could express  FasL and so  deliver a  death signal has been 
suggested  (22),  but not yet  demonstrated.  To  investigate 
the role and cellular location of FasL in death induced by 
CD8 +  DC,  FasL  mutant gld  mouse  strains were  utilized 
(10,  15,  23).  When CD4 T  cells from C3H/HeJgld  were 
stimulated with B6 CD8- or CD8 + DC in the presence of 
exogenous IL-2,  the  difference between  the  proliferative 
responses was  maintained and was  equal to  that  obtained 
using normal T  cells,  indicating that  the  FasL was  being 
provided by the CD8 + DC (Fig. 5 A). When normal C3H 
CD4  T  cells were  stimulated by FasL-deficient CD8 +  or 
CD8-  DC  from B6.gld mice, there  was  still some differ- 
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ence  between  the  proliferative  responses  obtained,  al- 
though it was much less than with normal DC  (Fig. 5  B). 
This suggested a small part of the killing was inter-T cell 
(suicide or fratricide).  However,  when both  the  CD4  T 
cells  and  the  DC  were  isolated  from gld  mutant  mice 
(C3H.gld  and  B6.gld,  respectively)  there  were  equally 
strong CD4 T  cell-proliferative responses to  CD8 +  or to 
CD8- DC (Fig. 5  C), showing that CD8 + DC directly sig- 
naled  most  of the  T  cell  death  in  the  normal  cultures. 
TUNEL analyses on the gld cultures revealed no differences 
in the  level of apoptotic  cells between CD8  §  and CD8- 
DC,  confirming that in the  absence of FasL on both DC 
and T  cells, apoptosis was abrogated (not shown). 
To  test  directly  for  the  presence  of FasL,  we  stained 
CD8 +  and CDS-  DC  with the muFas-Fc fusion protein 
recently engineered by Lynch et al.  (10).  The CD8 + DC 
all stained strongly with  this  reagent,  whereas  the  CD8- 
DC included only a small proportion of positive cells (Fig. 
6).  Under these  conditions, only a  low  level  of staining 
could be detected on Con A-activated T  cells. It should be 
emphasized that freshly isolated, uncultured DC were used B 
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Figure 5.  The proliferative responses of normal and FasL mutant  CD4 
T cells to allogeneic normal and FasL mutant CD8 + and CD8- DC. Ex- 
periments were repeated two to four times and one representative exam- 
ple is shown.  Exogenous  IL-2 at  100 U/ml was added  to the cultures. 
Proliferation was assessed as described in Fig. 2. The background  with ei- 
ther CD4 T  cells or DC cultured  alone  was  <100  cpm.  (A) C3H.gld 
CD4 T cells were cultured with B6 CD8- DC (Q) or CD8 + DC (O) for 
3 d. (B) C3H CD4 T cells were cultured  with CD8- DC (0) or CD8 § 
DC (O) from mutant B6.gld mice for 3 d. (C) C3H.gld CD4 T cells were 
cultured with B6.gld CD8- DC (Q) or CD8 + DC (O) for 3 d. 
in  these  experiments,  suggesting  a  high  level of FasL  ex- 
pression is the normal state ofCD8 + DC within the mouse 
spleen. 
￿9  CDS- DC 
' 
FAS-LIGAND FLUORESCENCE 
Figure 6.  FasL  expression on the surface ofCD8 + and CD8- DC. [m- 
munofluorescence  profiles represent  the binding of a muFas-Fc  fusion 
protein to B6  splenic DC.  The  CD8  + and  CD8-  DC  analyzed were 
equivalent to the sorted cells used for functional assays (see Fig. 1). Back- 
ground staining (broken line) is with purified human lgG. Other similar fu- 
sion  proteins  (e.g.,  muCTLA4-Fc),  even when positive  on DC,  gave 
much lower staining with httle difference between CD8 + and CD8- DC. 
The experiments have been repeated four times with similar results. 
Discussion 
Our  results  lead  to  the  conclusion  that  CD8 +  DC  ex- 
press FasL and so are functionally specialized for killing ac- 
tivated, Fas-expressing CD4  T  cells. By using mouse strains 
with  genetic  null-mutations  for  Fas  and  FasL,  Ipr/lpr  and 
gld/gld,  respectively, we demonstrated  that  FasL-expressing 
CD8 + DC  are functionally capable  of ehminating interact- 
ing  CD4  T  cells.  Although  we  have  used  CD8~  as  a 
marker  for  the  separation  of DC,  there  is  no  evidence to 
date that CD8a  itself is functionally important.  Since some 
CD8-  DC  express  FasL  (Fig.  6),  the  FasL  itself is  poten- 
tially a better marker for the complete segregation of stimu- 
latory from regulatory DC. 
This  study  establishes  that  murine  splenic  DC  can  be 
subdivided  phenotypically  and  functionally  into  two  dis- 
tinct populations based on their expression of CD8ot and of 
FasL.  CD8 + DC  are found in other lymphoid tissues  (5, 6); 
their function and level of FasL expression are currently be- 
ing  assessed.  Since  the  CD8 +  DC  of thymus  represent  a 
distinct  lineage  (6,  24),  we  suspect  the  CD8-  and  CD8 + 
DC  of spleen  differ  in  lineage  origin.  The  present  study 
demonstrates  that  they  differ in  function.  The  CD8-  DC 
1794  T  Cell Apoptosis by Dendritic Cells behave as expected for "conventional" DC, very efficiently 
stimulating CD4 T  cell responses. The CD8 + DC, in con- 
trast, constantly express high levels of FasL and thereby are 
able to kill interacting CD4 T  cells. 
The  expression  of FasL  by  testicular Sertoli  cells  (25), 
and  by parenchymal  cells of the  anterior  chamber  of the 
eye (26),  enables them to kill any activated, Fas-expressing 
T  cells  and  makes  these  tissues  immune-privileged sites. 
The  presence  of FasL  +  CD8 +  DC  within  a  tissue should 
likewise eliminate  or restrict T  cell responses  to  antigens 
presented by these DC,  either in order to regulate normal 
T  cell responses to foreign antigens or to purge the tissue of 
self-reactive CD4 T  cells. We envisage that the expression 
of FasL on the same DC that presents antigen and activates 
naive T  cells is an  effective way to block responses at an 
early stage, in contrast to the suicidal effect of FasL on acti- 
vated  T  cells  that  would  limit  responses  at  a  later  stage 
when  the  number  of activated T  cells becomes  too high. 
Whole animal approaches are now needed to assess the rel- 
ative  importance  of different  FasL-expressing cells in  the 
control of immune responses. 
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